These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 36868123)
21. Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma. Teng L; Deng W; Lu J; Zhang J; Ren X; Duan H; Chuai S; Duan F; Gao W; Lu T; Wu H; Liang Z Oncotarget; 2017 Mar; 8(13):22023-22033. PubMed ID: 28423545 [TBL] [Abstract][Full Text] [Related]
22. Ultrasound and cytological characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features compared to papillary carcinomas. Boursier L; Clerc Urmes I; Garon J; Klein M; Demarquet L Ann Endocrinol (Paris); 2020 Feb; 81(1):28-33. PubMed ID: 32081363 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of poorly differentiated carcinoma in Japanese Society of Thyroid Surgery in a series of papillary thyroid carcinoma patients: comparison with risk classification system in Kuma Hospital. Ito Y; Hirokawa M; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A Endocr J; 2012; 59(9):817-21. PubMed ID: 22673534 [TBL] [Abstract][Full Text] [Related]
24. Diffuse intrathyroidal dissemination of papillary thyroid carcinoma with no stromal fibrosis at presentation: A pattern of aggressive differentiated thyroid carcinoma. Fang H; Si Y; Wang C; Gong Q; Liu C; Wang S Pathol Res Pract; 2021 Aug; 224():153510. PubMed ID: 34329840 [TBL] [Abstract][Full Text] [Related]
25. Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism. Ma J; Mao Z; Yao Y; Lu Y; Wang H; Yang Y; Yang J; Wang W; Teng L BMC Surg; 2021 Sep; 21(1):335. PubMed ID: 34488715 [TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas. Lin JD; Chao TC; Hsueh C Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992 [TBL] [Abstract][Full Text] [Related]
27. Blood preoperative neutrophil-to-lymphocyte ratio is correlated with TNM stage in patients with papillary thyroid cancer. Gong W; Yang S; Yang X; Guo F Clinics (Sao Paulo); 2016 Jul; 71(6):311-4. PubMed ID: 27438563 [TBL] [Abstract][Full Text] [Related]
28. Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype. Zhou J; Wang WR; Zhang HF; Gao QQ; Wang WB; Zhu JH; Han YS; Chen J; Ma TH; Zhang XY; Teng XD Front Endocrinol (Lausanne); 2023; 14():1138100. PubMed ID: 37124750 [TBL] [Abstract][Full Text] [Related]
29. Assessment of preoperative thyroglobulin levels in papillary thyroid cancer. Melik MA; Baskonus I; Yilmaz L J Cancer Res Ther; 2022; 18(4):1042-1044. PubMed ID: 36149159 [TBL] [Abstract][Full Text] [Related]
30. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma. Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746 [TBL] [Abstract][Full Text] [Related]
31. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence. Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306 [TBL] [Abstract][Full Text] [Related]
32. Comparison of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with thyroiditis and papillary tumors. Ari A; Gunver F J Int Med Res; 2019 May; 47(5):2077-2083. PubMed ID: 30909773 [TBL] [Abstract][Full Text] [Related]
33. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346 [TBL] [Abstract][Full Text] [Related]
34. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls. Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297 [TBL] [Abstract][Full Text] [Related]
35. Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer Variants. Ho AS; Luu M; Shafqat I; Mallen-St Clair J; Chen MM; Chen Y; Jain M; Ali N; Patio C; Filarski CF; Lin DC; Bankston H; Braunstein GD; Sacks WL; Zumsteg ZS Thyroid; 2021 Oct; 31(10):1549-1557. PubMed ID: 34470466 [No Abstract] [Full Text] [Related]
36. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas. Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016 [TBL] [Abstract][Full Text] [Related]
38. Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma. Zhan L; Feng HF; Yu XZ; Li LR; Song JL; Tu Y; Yuan JP; Chen C; Sun SR BMC Surg; 2022 Jun; 22(1):235. PubMed ID: 35725426 [TBL] [Abstract][Full Text] [Related]
39. Solid papillary thyroid carcinoma with Hashimoto's thyroiditis: description of a further case with challenging cytological features. Fulciniti F; Barizzi J; Trimboli P; Giovanella L BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30659000 [TBL] [Abstract][Full Text] [Related]
40. The Inverse Association of Serum Magnesium with Papillary Thyroid Cancer in Thyroid Nodules: a Cross-Sectional Survey Based on Thyroidectomy Population. Xu H; Hu X; Li J; Nie Z; Kang S; Liu H; Wang Y; Jia X; Lyu Z Biol Trace Elem Res; 2023 Jul; 201(7):3279-3289. PubMed ID: 36227448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]